The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Diabetic neuropathy
Abstract
The global epidemic of prediabetes and diabetes has led to a corresponding epidemic of complications of these disorders. The most prevalent complication is neuropathy, of which distal symmetric polyneuropathy (for the purpose of this Primer, referred to as diabetic neuropathy) is very common. Diabetic neuropathy is a loss of sensory function beginning distally in the lower extremities that is also characterized by pain and substantial morbidity. Over time, at least 50% of individuals with diabetes develop diabetic neuropathy. Glucose control effectively halts the progression of diabetic neuropathy in patients with type 1 diabetes mellitus, but the effects are more modest in those with type 2 diabetes mellitus. These findings have led to new efforts to understand the aetiology of diabetic neuropathy, along with new 2017 recommendations on approaches to prevent and treat this disorder that are specific for each type of diabetes. In parallel, new guidelines for the treatment of painful diabetic neuropathy using distinct classes of drugs, with an emphasis on avoiding opioid use, have been issued. Although our understanding of the complexities of diabetic neuropathy has substantially evolved over the past decade, the distinct mechanisms underlying neuropathy in type 1 and type 2 diabetes remains unknown. Future discoveries on disease pathogenesis will be crucial to successfully address all aspects of diabetic neuropathy, from prevention to treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic neuropathy involves various syndromes, such as mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy, among which distal symmetric polyneuropathy is very prevalent (108).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [108]
Citations
Cites
Items 201–225 of 225
Vibratory and thermal thresholds in diabetics with and without clinical neuropathy
Jensen, T. S., Bach, F. W., Kastrup, J., Deigaard, A., & Brennum, J. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04963.x · Cited by 55
Li, Q. S., Cheng, P. Y., Favis, R., Wickenden, A., Romano, G. J., & Wang, H. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000205 · Cited by 54
Suzuki, Y., Sato, J., Kawanishi, M., & Mizumura, K. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00033-0 · Cited by 54
Longitudinal patient-oriented outcomes in neuropathy
Callaghan, B. C., Kerber, K. A., Langa, K. M., Banerjee, M., Rodgers, A. F., McCammon, R. J., Burke, J. F., & Feldman, E. L. (2015) · Neurology · doi:10.1212/wnl.0000000000001714 · Cited by 53
Self-citationPregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Raskin, P., Huffman, C., Toth, C. C., Asmus, M. J., Messig, M., Sanchez, R. J., & Pauer, L. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31829ea1a1 · Cited by 52
Regulation and dysregulation of axon infrastructure by myelinating glia
Pan, S., & Chan, J. R. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702150 · Cited by 52
Prabodha, L. B. L., Sirisena, N. D., & Dissanayake, V. H. W. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8641942 · Cited by 51
Fernyhough, P., & McGavock, J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00027-8 · Cited by 50
Nowicki, M., Müller, K., Serke, H., Kosacka, J., Vilser, C., Ricken, A. M., & Spanel‐Borowski, K. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22205 · Cited by 45
Hansen, C. S., Jensen, T. M., Jensen, J. S., Nawroth, P. P., Fleming, T. H., Witte, D. R., Lauritzen, T., Sandbaek, A., Charles, M., Fleischer, J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12753 · Cited by 43
Delcroix, J.-D., Michael, G. J., Priestley, J. V., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1779 · Cited by 41
The Influence of Sulindac on Experimental Streptozotocin-Induced Diabetic Neuropathy
Zochodne, D. W., & Ho, L. T. V. T. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100041160 · Cited by 39
Self-citationZenker, J., Poirot, O., Charles, A.-S. D. P., Arnaud, E., Médard, J., Lacroix, C., Küntzer, T., & Chrast, R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-12.2012 · Cited by 38
Hur, J., O’Brien, P. D., Nair, V., Hinder, L. M., McGregor, B. A., Jagadish, H. V., Kretzler, M., Brosius, F. C., & Feldman, E. L. (2016) · Diabetologia · doi:10.1007/s00125-016-3913-8 · Cited by 38
Self-citationNaVchannel variants in patients with painful and nonpainful peripheral neuropathy
Wadhawan, S., Pant, S., Golhar, R., Kirov, S. A., Thompson, J., Jacobsen, L., Qureshi, I., Ajroud‐Driss, S., Freeman, R. L., Simpson, D. M., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000207 · Cited by 38
Recognition and management of psychosocial issues in diabetic neuropathy
Vileikytė, L., & Gonzalez, J. S. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00013-8 · Cited by 36
Kobayashi, M., Chandrasekhar, A., Cheng, C., Martinez, J. A., Ng, H., de la Hoz, C. L. R., & Zochodne, D. W. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028225 · Cited by 32
Self-citationModulation of diet‐induced mechanical allodynia by metabolic parameters and inflammation
Cooper, M. A., Ryals, J. M., Wu, P. Y., Wright, K., Walter, K. R., & Wright, D. E. (2016) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12199 · Cited by 31
Self-citationGarcía‐Pérez, E., Schönberger, T., Sumalla, M., Stierstorfer, B., Solà, R., Doods, H. N., Serra, J., & Gorodetskaya, N. (2018) · European Journal of Pain · doi:10.1002/ejp.1235 · Cited by 28
Discovering early diabetic neuropathy from epidermal nerve fiber patterns
Andersson, C., Guttorp, P. M., & Särkkä, A. (2016) · Statistics in Medicine · doi:10.1002/sim.7009 · Cited by 24
Painful Diabetic Neuropathy: Many Similarly Effective Therapies With Widely Dissimilar Costs
Callaghan, B. C., & Feldman, E. L. (2014) · Annals of Internal Medicine · doi:10.7326/m14-2157 · Cited by 21
Self-citationIndINeP Study Group (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00208.x · Cited by 13
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
Russell, J. W., & Zilliox, L. A. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4719 · Cited by 9
Self-citationBeghi, E., Treviso, M., Ferri, P., et al. (1988) · The Italian Journal of Neurological Sciences · doi:10.1007/bf02337012 · Cited by 3
Sugimoto, K., Murakawa, Y., Zhang, W., et al. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200009/10)16:5
Research works printed but not linked: 5
- International Diabetes Federation. IDF Diabetes Atlas - 8th edition: key messages. IDF https://diabetesatlas.org/key-messages.html (2019).
- Callaghan, B. C., Little, A. A., Feldman, E. L. & Hughes, R. A. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, CD007543 (2012). This analysis of clinical studies evaluating the impact of glycaemic control on neuropathy outcomes in T1DM and T2DM reveals that enhanced glucose control significantly attenuates neuropathy development in T1DM but not in T2DM.
- Moore, R. A., Straube, S., Wiffen, P. J., Derry, S. & McQuay, H. J. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst. Rev. 8, CD007076 (2009).
- Derry, S., Wiffen, P. J., Aldington, D. & Moore, R. A. Nortriptyline for neuropathic pain in adults. Cochrane Database Syst. Rev. 1, CD011209 (2015).
- Amalraj, M. J., Anitha Rani, A. & Viswanathan, V. A study on positive impact of intensive psychological counseling on psychological well-being of type 2 diabetic patients undergoing amputation. Int. J. Psychol. Couns. 9, 10–16 (2017).
Cited by
Sorted by citations
Jensen, T. S., Karlsson, P., Gylfadottir, S. S., Andersen, S. T., Bennett, D. L., Tankisi, H., Finnerup, N. B., Terkelsen, A. J., Khan, K., Themistocleous, A. C., et al. (2021) · Brain · doi:10.1093/brain/awab079 · Cited by 265
Self-citationAntiproliferative and palliative activity of flavonoids in colorectal cancer
Fernández, J., Silván, B., Entrialgo-Cadierno, R., Villar, C. J., Capasso, R., Uranga, J. A., Lombó, F., & Abalo, R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112241 · Cited by 258
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors
Vettoretti, M., Cappon, G., Facchinetti, A., & Sparacino, G. (2020) · Sensors · doi:10.3390/s20143870 · Cited by 176
Extracellular matrix-inspired biomaterials for wound healing
Hosty, L., Heatherington, T., Quondamatteo, F., & Browne, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09750-9 · Cited by 63
Metadata
- Authors
- Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V.
- Affiliations
- University of Michigan (US)
- University of Alberta (CA)
- University of Kansas Medical Center (US)
- University of Oxford (GB)
- University Health Network (CA)
- VA Maryland Health Care System (US)
- M.V. Hospital for Diabetes and Diabetes Research Centre (IN)
- Corresponding author
- Feldman, Eva L.
- ORCID
- Venue
- Nature Reviews Disease Primers
- Published
- 2019-06-13
- Volume
- 5
- Issue
- 1
- Pages
- 41-41
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211145818
- Cited by
- 1,697
- References
- 225
- Citations by year
- 2026: 246 · 2025: 337 · 2024: 364 · 2023: 272 · 2022: 220 · 2021: 149 · 2020: 78 · 2019: 13
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (101RX001030)
- Diabetes Action Research and Education Foundation
- Wellcome Trust (102645, 102645/Z/13/Z, 202747/Z/16/Z, 202747/Z/16/)
- Diabetes Canada
- European Commission (HORIZON2020)
- Novo Nordisk Fonden (NNF14OC0011633)
- National Institutes of Health (R01D107956)
- Clinical Science Research and Development
- Geriatric Research Education and Clinical Center
- Canadian Institutes of Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK082841, R01DK115687, R01DK107007)
- National Institute of Neurological Disorders and Stroke (K23NS079417)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetic neuropathy, distal symmetric polyneuropathy, type 1 diabetes, type 2 diabetes, glycemic control, prediabetes, neuropathic pain, neuropathy prevention, neuropathy treatment, opioid avoidance, pathogenesis
- MeSH terms
- Serotonin and Noradrenaline Reuptake Inhibitors, Analgesics, Opioid, Diabetic Neuropathies, Humans, Hyperglycemia, Hyperlipidemias, Mass Screening, Quality of Life, Risk Factors, Prevalence, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
